Karcz-Kubicha M, Liljequist S
Department of Clinical Neuroscience, Karolinska Hospital, Stockholm, Sweden.
Psychopharmacology (Berl). 1995 Jul;120(1):49-56. doi: 10.1007/BF02246144.
The effect of post-ethanol administration of NMDA and non-NMDA receptor antagonists on the development of environment-dependent ethanol tolerance was studied in C57B1 mice. Ethanol tolerance was produced by daily injections of ethanol (3.5 g/kg, IP) in the same experimental environment and measured as ethanol-produced "sleep-time" during 5 consecutive days. The non-competitive NMDA receptor antagonist, dizocilpine (MK-801; 0.1 mg/kg, IP), and the competitive NMDA receptor antagonist, CGP 39551 (5 mg/kg, IP), both given 120 min after the administration of ethanol, inhibited the development of tolerance to the hypnotic actions of ethanol. In contrast, the development of ethanol tolerance was not altered by administration of the specific AMPA/KA receptor blocking agents, NBQX (10 mg/kg, IP), and LY326325 (2.5 mg/kg, IP), respectively. Modulation of NMDA receptor activity by drugs like NMDA, d-cycloserine, and milacemide, which are known to enhance learning and memory in rodents, had no significant effect on the development of ethanol tolerance. Our present data confirm and extend previous findings which indicate that NMDA, but not non-NMDA, glutamate receptors may play an important role in the neuroadaptive processes associated with the development of ethanol tolerance.
在C57B1小鼠中研究了乙醇给药后给予N-甲基-D-天冬氨酸(NMDA)和非NMDA受体拮抗剂对环境依赖性乙醇耐受性发展的影响。通过在相同实验环境中每日腹腔注射乙醇(3.5 g/kg)产生乙醇耐受性,并将其作为连续5天内乙醇诱导的“睡眠时间”进行测量。非竞争性NMDA受体拮抗剂地佐环平(MK-801;0.1 mg/kg,腹腔注射)和竞争性NMDA受体拮抗剂CGP 39551(5 mg/kg,腹腔注射)均在乙醇给药120分钟后给予,抑制了对乙醇催眠作用耐受性的发展。相比之下,分别给予特异性α-氨基-3-羟基-5-甲基-4-异恶唑丙酸/海人藻酸(AMPA/KA)受体阻断剂NBQX(10 mg/kg,腹腔注射)和LY326325(2.5 mg/kg,腹腔注射),并未改变乙醇耐受性的发展。已知能增强啮齿动物学习和记忆的药物如NMDA、d-环丝氨酸和米拉酰胺对NMDA受体活性的调节,对乙醇耐受性的发展没有显著影响。我们目前的数据证实并扩展了先前的研究结果,表明NMDA而非非NMDA谷氨酸受体可能在与乙醇耐受性发展相关的神经适应性过程中起重要作用。